Effects of Prebiotics and Synbiotics on  Gut Microbiota

Honeybees can provide humans with various bee products, such as pollen, honey, royal jelly, and propolis (Nainu et al. 2021). Honeybees are also important pollinators worldwide (Khalifa et al. 2021), increasing crop yields and maintaining the stability of ecosystems and the diversity of plant communities (Dai et al. 2018). A previous study has shown that 85% of the main crops directly related to food rely on pollination by insects such as honeybees (Klein et al. 2007). The gut microbial composition of honeybees is simpler than that of humans (Kwong and Moran 2016). The honeybee gut harbors a diverse microbial community, among which lactic acid bacteria (LAB) and bifidobacteria are beneficial in the intestine (Ge et al. 2021). On the contrast, some pathogenic bacteria such as Paenibacillus larvae and Melissococcus pluton have been found to cause diseases in honeybees (Fünfhaus et al. 2018). Both probiotics and prebiotics benefit the intestinal health of animals and humans by improving the gut microbiota balance, epithelial barrier, and immune function of hosts (Sanders et al. 2019). Thus, maintaining gut homeostasis is of great significance in honeybees.

Apis cerana, a native honeybee species in China, has a beekeeping history of more than 1700 years (Wang et al. 2021). In 2017, the number of A. cerana was estimated to be two million in China and play a critical role in crop production (Chen et al. 2017). Antibiotics have been commonly used in bee colonies to treat and control diseases of honeybees caused by bacterial pathogens such as P. larvae (Raymann et al. 2017). However, emerging evidence has reported that antibiotic treatment could reduce gut microbial diversity, weaken nutrient metabolism and immune function, affect physiological and behavioral development, and even increase mortality in honeybees (Raymann et al. 2017; Ortiz-Alvarado et al. 2020; Duan et al. 2021). Therefore, the need for alternatives to antibiotics to maintain honeybee fitness has emerged.

A prebiotic is defined as “a substrate that is selectively utilized by host microorganisms conferring a health benefit” by the International Scientific Association for Probiotics and Prebiotics (ISAPP) (Gibson et al. 2017). Commonly used prebiotics include inulin (INU), fructo-oligosaccharides (FOS), xylo-oligosaccharides (XOS), and isomalto-oligosaccharides (IMO) (Carlson et al. 2017; Poeker et al. 2018; Sorndech et al. 2018; Tandon et al. 2019). Prebiotics can alter the gut microbiota composition and promote host health by accumulating organic acids (Rastall and Gibson 2015). Prebiotics, which mainly favor bifidobacteria and lactobacilli, can be fermented to generate short-chain fatty acids (SCFAs) with colonic bacteria to fight chronic diseases (Tornero-Martínez et al. 2019). A synbiotic is a mixture comprising live microorganisms and substrate(s), selectively utilized by host microorganisms that confer a health benefit on the host (Swanson et al. 2020). Lactic acid bacteria, the most widely used probiotics, antagonize the pathogenic bacteria and influence the gut microbiota of the honeybees (Williams 2010; Audisio et al. 2015; Ramos et al. 2020). These studies highlight the potential of prebiotics and synbiotics modifying the gut microbiota of honeybees and consequently improving host health. However, little is known about the effects of prebiotics and synbiotics on the intestinal microbiota of A. cerana. This study aimed to determine the prebiotic properties of selected commonly used prebiotics using in vitro fermentation of gut microbiota of A. cerana. The most prebiotic potential was observed in IMO. Furthermore, IMO’s in vitro symbiotic effect with lactobacilli, which has shown probiotic properties in our previous study, was determined. The obtained results may provide insight into the potential outcomes of IMO to improve the health of honey bees.

Experimental

Materials and Methods

LAB strains and incubation condition. Strains Limosilactobacillus helveticus KM7 (CGMCC No. 16042) and Lactobacillus reuteri LP4 (CGMCC No. 16043) deposited in the China General Microbiological Culture Collection Center, were isolated from the intestines of adult worker honeybees from A. cerana in our previous study and showed probiotic properties (Wang 2018; Lei et al. 2020). Each strain was incubated with Man Rogosa and Sharpe (MRS) broth at 37°C and grown to stationary phase for 24 h in an anaerobic jar (Anaero-Jar TM 2.5l, Oxoid Ltd., Basingstoke, UK), including a gas-generating package (AnaeroPack, Mitsubishi Gas Chemical Co., Tokyo, Japan) prior to experiments. After centrifuging at 3,944 × g for 10 min at 4°C, the pellets were resuspended in MRS broth.

In vitro fermentation of A. cerana gut microbiota in the presence of prebiotics

Gut homogenate. Thirty-six naturally foraging adult worker bees of A. cerana, aged 18 days, were collected in summer (July) from a single colony, with robust population and without identified diseases, maintained in the apiary of the Yunnan Agricultural University in Kunming, China (longitude 102°45′30.5″ E, latitude 25°8′5.8″ N). Collected bees were placed in 50 ml sterilized centrifuge tubes and then pumped in CO₂ until the honeybees were unconscious. The whole bees were washed in 75% (v/v) ethanol. The guts were dissected aseptically using forceps and 1 g of gut samples were diluted with 10 ml of phosphate buffer saline (PBS), followed by cutting into pieces in an anaerobic workstation. The collection of gut samples were processed within 15 min. The experiment was performed in triplicates.

Gut fermentations. FOS (catalog No. S11133), INU (catalog No. S11143), IMO (catalog No. S11134), and XOS (catalog No. S11137) (Shanghai Yuanye Biological Technology Co., Ltd, Shanghai, China) were chosen, and glucose (GLU) was used as a nonselective control. In vitro, static batch culture fermentations were performed with five FOS, INU, IMO, XOS, and GLU treatments in three replicates using the serum bottle, as described by Rycroft et al. 2001) the simple modification. Briefly, the basal medium (peptone 2 g/l, yeast extract 2 g/l, NaCl 0.1 g/l, K₂HPO₄ 0.04 g/l, KH₂PO₄ 0.04 g/l, MgSO₄ · 7H₂O 0.01 g/l, CaCl₂ · 6H₂O 0.01 g/l, NaHCO₃ 2 g/l, L-cysteine 0.5 g/l, bile salt 0.5 g/l, Tween80 2 ml/l, vitamin K₁ 10 μl, and hemin chloride 0.05 g/l) (100 ml) supplemented with 1% GLU, 1% FOS, 1% INU, 1% IMO, or 1%XOS was placed into the serum bottle and sterilized. According to the literature (Likotrafiti et al. 2014; Henrique-Bana et al. 2020) and our preliminary study, selected prebiotics were added to a final concentration of 1% (m/v). Afterward, the bottles were refluxed with O₂-free N₂ and covered. Each bottle filled with 100 ml sterilized medium was then inoculated 1 ml of the gut homogenate and maintained at 37°C in an anaerobic jar (AnaeroJar TM 2.5l, Oxoid Ltd., Basingstoke, UK) including a gas-generating package (AnaeroPack, Mitsubishi Gas Chemical Co., Tokyo, Japan). Samples were collected after 0, 6, 12, and 24 h of fermentation to analyze viable microbial cells and pH. In the preliminary study, no total cultivable bacteria, Bifidobacterium, LAB, Enterococcus, and total fungi were detected in the basal medium in in vitro culture of gut microbiota of A. cerana. The explanation may be that the basal medium without supplemented carbohydrates could not support the in vitro growth of honeybees gut microbe (Long et al. 2015). Therefore, in the present study, the effect of the basal medium in the absence of prebiotics or glucose was not investigated.

Enumeration of Bifidobacterium and LAB. The number of Bifidobacterium and LAB was determined using the plate count method described by Abdel-Moneim et al. (2020). Briefly, 1 ml fermentation broth was 10-fold serially diluted in PBS. The viable count was enumerated by plating onto MRS agar (Catalog No.: HB0384-5, Qingdao Haibo Biotechnology Co., Ltd, Qingdao, China) or Bifidobacterium selective medium agar containing 10 g/l of peptone, 5 g/l of liver extract, 3 g/l of beef extract, 5 g/l of yeast extract, 8 g/l of peptone from casein, 0.5 g/l dissolved starch, 1 g/l of NaCl, 1 g/l of K₂HPO₄, 1 g/l of KH₂PO4, 10 g/l of GLU, 0.01 g/l of FeSO₄ · 7H₂O, 0.005 g/l of MnSO₄, 0.5 g/l of L-cysteine, 1 ml of Tween80, and 20.0 g/l of agar (Catalog No.: HB0394, Qingdao Haibo Biotechnology Co., Ltd, Qingdao, China) within 15 min and incubated at 37°C in an anaerobic jar (AnaeroJar TM 2.5L, Oxoid Ltd., Basingstoke, UK) including an anaeroPack (Mitsubishi Gas Chemical Co., Tokyo, Japan) for 48 h. The colonies grown on Bifidobacterium selective medium for further microscopic examination were identified. Enumeration was repeated three times, and the number of microbial colonies (CFU) was recorded.

Measurement of pH. After fermentation at 0, 6, 12, and 24 h, 10 ml of fermentation broth from each culture bottle was taken and transferred to 50 ml sterile centrifuge tube. The pH meter (Shanghai INESA Instrument Co., Ltd, Shanghai, China) was used to measure pH.

In vitro fermentation of A. cerana gut microbiota in the presence of prebiotic IMO combined with L. helveticus KM7 or L. reuteri LP4

Gut fermentations. Gut samples and basal medium with 1% (g/v) IMO were prepared as described above. One milliliter of gut homogenate and 1 ml of freshly cultured L. helveticus KM7 and L. reuteri LP4 (10⁵, 10⁶, or 10⁷ CFU/ml) was seeded into 100 ml of basal medium supplemented with IMO and maintained at 37°C in an anaerobic jar (AnaeroJar TM 2.5L, Oxoid Ltd., Basingstoke, UK) including an anaeroPack (Mitsubishi Gas Chemical Co., Tokyo, Japan). IMO without the presence of Lactobacillus strains was served as control. Samples were collected after 0, 6, 12, and 24 h of fermentation to measure total bacteria, bacteria, Bifidobacterium, fungi, and Enterococcus, respectively.

Enumeration of bacteria and fungi and analysis of pH. After fermentation of 0, 6, 12, and 24 h, 1 ml of fermentation broth was collected and mixed with 9 ml of PBS. Enumeration of A. cerana gut microbiota was performed using plate count methods. Serial dilutions were performed as described above and placed onto different selective media to determine the microbial amounts. Agars of MRS and Bifidobacterium selective medium were used as described above to count LAB and Bifidobacterium, respectively. The diluted broth was placed onto Luria Bertani nutrient agar (Catalog No.: HB0129, Qingdao Haibo Biotechnology Co., Ltd, Qingdao, China) and incubated at 30°C for 48 h to count total aerobic bacteria (Abdel-Moneim et al. 2020). The dilution was placed onto Enterococcus selective agar (Bile Aesculin Azide Agar, catalog No.: HB0133, Qingdao Haibo Biotechnology Co., Ltd, Qingdao, China) and incubated at 37°C for 48 h to count Enterococcus sp., which can be recognized by producing colonies with a black halo around (hydrolysis of esculin) (Śliżewska et al. 2019). To enumerate total fungi, the dilutions were placed onto potato dextrose agar (Catalog No.: HB0233, Qingdao Haibo Biotechnology Co., Ltd, Qingdao, China) with 0.01% (w/v) chloramphenicol and incubated at 28°C for 72 h to count total fungi number with the addition of microscopic examination, based on China National Standard Microbiological Examination of Foods (GB4789.15-2016). For pH measurement, fermentation broth samples were collected and subjected to analysis as described above.

Statistical analysis. Experimental data analysis was performed using SPSS18.0. One-way ANOVA was used to compare the differences between the data of multiple different treatment groups. The independent student t-test was performed to compare the data differences between the two treatment groups. p < 0.05 Indicated a significant difference. The results were expressed as mean ± standard deviation (SD).

Results

In vitro fermentation of A. cerana gut microbiota in the presence of prebiotics

Bididobacterium and LAB enumeration. As shown in Table I, Bifidobacterium multiplied over time in each group. Compared to the GLU group, the Bifidobacterium number in the IMO group significantly rose from fermentation for 6 h until 24 h (p < 0.05). At the fermentation of 12 h, the number of Bifidobacterium in INU, IMO, and XOS group was significantly higher than that in the GLU group (p < 0.05), and in the IMO group the number was significantly higher than in INU and XOS groups (p < 0.05). At 24 h, Bifidobacterium amount in the IMO group was significantly more than those in GLU, INU, FOS, and XOS groups (p<0.05). Bifidobacterium multiplication benefited from four kinds of prebiotics: IMO, INU, FOS and XOS. IMO provided the best promotion effect in the intestinal of A. cerana.

Table I

Number of Bifidobacterium and LAB in the prebiotic fermentation broth of A. cerana gut microbiota.

Number of gut microbiota / Log₁₀ (CFU/ml)	Time (h)	Treatment
Number of gut microbiota / Log₁₀ (CFU/ml)	Time (h)	GLU	FOS	INU	IMO	XOS
Bifidobacterium	0	5.85 ± 0.06^Ca	5.82 ± 0.05^Ca	5.83 ± 0.02^Ca	5.82 ± 0.01^Ca	5.80 ± 0.02^Ca
	6	5.63 ± 0.03^Db	5.66 ± 0.16^Cab	5.83 ± 0.13^Cab	5.94 ± 0.19^Ca	5.81 ± 0.15^Cab
	12	6.99 ± 0.08^Bc	6.46 ± 0.25^Bd	7.79 ± 0.08^Bb	8.31 ± 0.36^Ba	7.43 ± 0.24^Bb
	24	8.15 ± 0.05^Ad	8.41 ± 0.08^Ac	8.85 ± 0.02^Ab	9.10 ± 0.12^Aa	8.52 ± 0.18^Ac
LAB	0	5.01 ± 0.02^Da	4.99 ± 0.03^Ba	5.00 ± 0.02^Da	5.01 ± 0.05^Ca	4.98 ± 0.02^Ca
	6	6.03 ± 0.03^Cb	5.06 ± 0.16^Bc	6.10 ± 0.09^Cab	6.34 ± 0.19^Ba	5.21 ± 0.15^Cc
	12	7.29 ± 0.08^Bc	5.76 ± 0.25^Ad	8.09 ± 0.08^Bab	8.28 ± 0.33^Aa	7.73 ± 0.24^Bb
	24	7.76 ± 0.14^Ac	5.67 ± 0.35^Ad	8.36 ± 0.11^Aab	8.61 ± 0.02^Aa	8.19 ± 0.16^Ab

GLU – glucose; FOS – fructo-oligosaccharides; INU – inulin; IMO – isomalto-oligosaccharides; XOS – xylo-oligosaccharides

A-D – different uppercase letters between treatments using the same prebiotic at the different fermentation timing denote significance (p < 0.05)

a-d – different lowercase letters between different treatments at the same time fermentation point denote significance (p < 0.05)

The number of LAB in each group of the fermentation broth supplemented with oligosaccharides or glucose increased in a time-dependent manner (Table I). Compared to the GLU group, IMO showed a significant increasing effect on LAB growth at all time points. The LAB number in both INU and XOS groups was higher than those in the GLU group after 12 and 24 h of fermentation. There was no significant difference in the LAB number between IMO and INU groups (p > 0.05). In vitro fermentation of IMO and INU can significantly promote the LAB multiplication in the gut of A. cerana.

pH value. The pH value in all groups was significantly reduced, and the extent of pH reduction varied with prebiotics type (Table II). The pH value in each group did not differ after 6 h of fermentation (p > 0.05). After 12 h of fermentation, compared to the GLU group, the pH value in INU, IMO and XOS groups was reduced significantly (p<0.05), while the value of pH in the FOS group was significantly higher (p < 0.05). After 24 h of fermentation, compared to the GLU group, the pH value in INU, IMO and FOS groups was reduced significantly (p < 0.05), while the value of pH in the FOS group significantly increased (p < 0.05). Among all treatment groups, the lowest pH value was found in the IMO group after both 12 and 24 h of fermentation. These data indicate that in vitro fermentation of IMO could decrease pH value of intestinal microbial in adult worker A. cerana.

Table II

The pH value in the prebiotic fermentation broth of A. cerana gut microbiota.

Time (h)	pH value
Time (h)	GLU	FOS	INU	IMO	XOS
0	6.98 ± 0.03^Aa	7.00 ± 0.04^Aa	6.98 ± 0.06^Aa	7.01 ± 0.02^Aa	6.99 ± 0.03^Aa
6	6.89 ± 0.04^Ba	6.91 ± 0.05^Ba	6.89 ± 0.07^Aa	6.89 ± 0.03^Ba	6.90 ± 0.06^Ba
12	6.13 ± 0.07^Cb	6.31 ± 0.03^Ca	5.71 ± 0.02^Bd	5.57 ± 0.07^Ce	5.97 ± 0.05^Cc
24	5.78 ± 0.07^Db	6.22 ± 0.04^Da	5.59 ± 0.04^Cc	5.48 ± 0.03^Dd	5.65 ± 0.03^Dc

GLU – glucose; FOS – fructo-oligosaccharides; INU – inulin; IMO – isomalto-oligosaccharides; XOS – xylo-oligosaccharides

A-D – different uppercase letters between treatments using the same prebiotic at the different fermentation timing denote significance (p < 0.05)

a-d – different lowercase letters between different treatments at the same fermentation point time denote significance (p < 0.05)

In vitro fermentation of A. cerana gut microbiota in the presence of prebiotic IMO combined with L. helveticus KM7 or L. reuteri LP4

Bacteria enumeration. During 24 h in vitro fermentation, the combination of probiotic and IMO significantly increased the total bacteria number in the fermentation broth (Fig. 1A). Compared to IMO treatment, after 6, 12, and 24 h of fermentation, the number of L. helveticus KM7 adding groups and L. helveticus KM7 combined with IMO groups increased significantly (p < 0.05). Similarly, relative to the IMO group, significantly higher bacteria counts in the L. reuteri LP4 combined with IMO were observed after 6, 12, and 24 h of fermentation (p < 0.05). Inducing the IMO effect on bacteria combined with L. helveticus KM7 or L. reuteri LP4 was similar. These data indicated that the combination of IMO with L. helveticus KM7 or L. reuteri LP4 improved bacteria in vitro fermentation of intestinal microflora of adult worker honeybee of A. cerana.

Effect of IMO in combination with L. helveticus KM7 or L. reuteri LP4 on bacteria during the in vitro fermentation of A. cerana gut microbiota; A) the number of total bacteria, B) Bifidobacterium, C) LAB and D) Enterococcus were determined. IMO is the abbreviation of isomalto-oligosaccharides. A graphic was created with different treatment grouping on the x-axis and microbes counts on the y-axis.
* – significance between treatments using the different probiotic strains added at the same concentration for the same fermentation period (p < 0.05)
a-d – different lowercase letters between different treatments at the same time fermentation point denote significance (p < 0.05); results were expressed as mean ± SD (n = 3)

After 6 or 24 h of fermentation, the use of L. helveticus KM7 and IMO caused a significant increase in Bifidobacterium number in the fermentation broth relative to that of IMO alone (p < 0.05) (Fig. 1B). However, no significant difference was seen between IMO supplemented with L. helveticus KM7 inoculated at concentrations of 10⁵–10⁷ CFU/ml (p > 0.05). A similar effect was found in IMO supplemented with L. reuteri LP4. These results indicated that LAB and IMO synergistically facilitated Bifidobacterium proliferation in the fermentation broth of intestinal microflora of A. cerana.

The combination of IMO and L. helveticus KM7 significantly induced LAB growth in vitro in the fermentation broth of intestinal microflora of A. cerana (p < 0.05) (Fig. 1C). This inductive impact depended on the inoculation concentration of KM7 strain. After 24 h of fermentation, concurrent addition of 10⁷ CFU/ml of KM7 and IMO significantly increased LAB number in fermentation broth from that in IMO only (p < 0.05). Consistent with findings, the LAB number was also significantly higher in the fermentation broth supplemented with IMO compared to that in IMO only (p<0.05). The more significant inductive effect on LAB growth was observed with IMO combined with KM7 strain. These results revealed that L. helveticus KM7 and L. reuteri LP4 improved the LAB number in the fermentation broth of intestinal microbiota of A. cerana supplemented with IMO, and this effect was specific for LAB species.

Compared to the IMO group, after 6 and 12 h, IMO supplemented with L. helveticus KM7 did not significantly alter the number of Enterococcus while significantly reducing Enterococcus growth only after 24 h of in vitro fermentation (p < 0.05) (Fig. 1D). The inoculation concentration of L. helveticus KM7 did not reduce the Enterococcus number. Combination of IMO and L. reuteri LP4 of 107 CFU/ml inoculation concentration decreased the Enterococcus proliferation after 24 h of fermentation (p < 0.05), suggesting that only administration of an adequate number of L. reuteri LP4 combined with IMO could modulate Enterococcus growth. Concurrent addition of IMO and L. helveticus KM7 or L. reuteri LP4 significantly decreased number of Enterococcus in the in vitro fermentation broth of intestinal microbiota of A. cerana, respectively, and L. helveticus KM7 showed more remarkable ability than L. reuteri LP4.

Fungi enumeration. After 6, 12, and 24 h of fermentation, more numerous fungi in the in vitro fermentation groups of L. helveticus KM7 combined with IMO were detected than the IMO group (p<0.05) (Fig. 2). No significant differences among L. helveticus KM7 groups added at different doses were seen (p > 0.05). Interestingly, a combination of IMO with L. reuteri LP4 did not significantly change fungi growth at all indicated timing of in vitro fermentation (p > 0.05), suggesting that reducing the impact on the fungi growth of LAB when concurrently was dependent on LAB species. The strain of L. helveticus KM7 rather than L. reuteri LP4 combined with IMO could reduce the number of fungi in vitro fermentation broth of intestinal microbiota of adult worker bees of A. cerana.

Effect of IMO in combination with L. helveticus KM7 and L. reuteri LP4 on fungi during in vitro fermentation of A. cerana gut microbiota. IMO is the abbreviation of isomalto-oligosaccharides.
* – significance between treatments using the different probiotic strains added at the same concentration for the same fermentation period (p < 0.05)
a-d – different lowercase letters between different treatments at the same time fermentation point denote significance (p < 0.05); results were expressed as mean ± SD (n = 3)

pH value. Starting with 6 h during in vitro fermentation, a significant reduction in pH was found in groups of IMO with either L. helveticus KM7 or L. reuteri LP4 (p < 0.05) (Fig. 3). After 6 h, L. helveticus KM7 at medium (10⁶ CFU/ml) and high (10⁷ CFU/ml) concentrations, pH value in the fermentation broth of L. helveticus KM7 and IMO was lower than L. reuteri LP4 and IMO group significantly (p < 0.05). After 12 and 24 h, the pH value of groups with IMO and L. helveticus KM7 at the same concentration was significantly lower than that of those with IMO and L. reuteti LP4 (p < 0.05). Strain L. helveticus KM7 had a stronger impact than L. reuteri LP4. Decreasing pH values were dependent on the inoculation concentration. The combination of IMO with either L. helveticus KM7 or L. reuteri LP4 could lower the pH of in vitro fermentation broth of intestinal microbiota of A. cerana.

Effect of IMO in combination with L. helveticus KM7 and L. reuteri LP4 on pH during in vitro fermentation of A. cerana gut microbiota. IMO is the abbreviation of isomalto-oligosaccharides.
* – significance between treatments using the different probiotic strains added at the same concentration for the same fermentation period (p < 0.05)
a-d – Different lowercase letters between different treatments at the same fermentation time point denote significance (p < 0.05); results were expressed as mean ± SD (n = 3)

Discussion

In this study, the experiment design evaluated in vitro effects of prebiotics alone, and in combination with Lactobacillus on microbial composition and acid production of A. cerana microflora. Our results have shown that selected prebiotics including FOS, INU, IMO, and XOS stimulate the growth of LAB and Bifidobacterium compared to GLU, and this effect varied with the type of prebiotics. Lowered pH was also found with these selected prebiotics, reflecting bacterial metabolic activity induced with them. LAB and Bifidobacterium are commensals in A. cerana gut, providing beneficial effects and effects on growth of these strains could be used to evaluate prebiotics (Watson et al. 2013). LAB are recognized to be lactic acid producers in honeybees’ gut (Ellegaard et al. 2015) and increased numbers of these bacteria contribute to enhanced lactic acid levels with prebiotics treatment. Several in vitro and in vivo studies using these prebiotics have reported similar findings to our results. For instance, Fehlbaum et al. (2018) observed that FOS, inulin, GOS, and XOS caused the Bifidobacerium growth and XOS and GOS, but not FOS and inulin, resulted in the Lactobacillus growth after 24 h fermentation broth inoculated with adult fecal microbiota. An animal study reported that the intragastrical administration of FOS, GOS, or IMO to BALB/c mice for 17 days increased the fecal levels of Bifidobacterium and Lactobacillus, and beneficial effect on these bacteria was dependent on the type and the used dosages (Wang et al. 2017). In our study, prebiotic IMO showed greater inductive effects on LAB and Bifidobacterium and metabolism compared to other prebiotics. IMO has been a partly digestible carbohydrate and a well-established functional food in Asia for decades (Goffin et al. 2011). The ability of IMO to benefit intestinal microbiota has been reported in rats, pigs, and humans, and varied prebiotic potential compared to other types of prebiotics has been observed in several studies (Koleva et al. 2014; Okazaki and Katayama 2019; Logtenberg et al. 2021). For example, in a recent study comparing IMO and GOS in vitro fermentation using infant fecal inoculum of 2- and 8-week-old infants IMO showed more inductive effects on Bifidobacterium and acetate and lactate production than GOS (Logtenberg et al. 2021). By contrast, the results in rats fed a high-fat diet observed by Okazaki and Katayama (2019) suggested that both FOS increased fecal Bifidobacterium and Lactobacillus and IMO had no impact on these beneficial bacteria. Overall, this evidence suggests the impact of different prebiotics on intestinal microbiota composition may depend on prebiotics type, host species, and physiological conditions, which may contribute to IMO’s most favorable prebiotic properties on A. cerana in this study.

Increasing evidence in both in vitro and in vivo studies indicates that synbiotics, a combination of probiotics and prebiotics, have beneficial effects on modulating host microbiota composition and metabolism (Pandey et al. 2015). In our previous study, L. helveticus KM7 or L. reuteri LP4 derived from A. cerana gut have shown the potential probiotic properties and were chosen to evaluate the symbiotic effect combined with IMO. The data revealed that IMO combined with L. helveticus KM7 or L. reuteri LP4 exhibited symbiotic potential through improving proliferation of Bifidobacterium, LAB, and total bacteria and decreasing growth of total fungi and Enterococcus in A. cerana gut microbiota compared to IMO alone. In addition, lowered pH was observed in the combination of IMO with L. helveticus KM7 or L. reuteri LP4 relative to IMO alone, confirming the bacteria fermentation in Apis cerana gut microbiota. However, the increase in total LAB in vitro fermentation of A. cerana gut microbiota with IMO in the presence of lactobacilli might be due to the exogenously applied Lactobacillus, and this need to be elucidated in further study using molecular techniques in order to specify the inoculated or endogenous LAB. Bacteria present in the honeybee gut play a beneficial role in maintaining host health through helping utilize and absorb nutrients, protecting from xenobiotics, and acidifying the gut environment to reduce pathogens colonization (Raymann et al. 2018; Pachla et al. 2021). However, yeasts have been recognized as dominant fungi in the gut of the Apis genus, but the increased abundance of yeast has been related to diseases and malnutrition or response to antibiotics and insecticides (Gilliam and Prest 1972; Ptaszyńska et al. 2016). The infection with intestinal fungal pathogens such as Nosema apis and N. ceranae has been recognized to cause shortened lifespan and reduction in colony size of honeybees (Houdelet et al. 2021). Our results suggest that IMO combined with selected Lactobacillus strains maintain gut microbiota homeostasis of A. cerana. Stimulation of Bifidobacterium growth in A. cerana gut microbiota supplemented with IMO and Lactobacillus strains agreed with the report of Gmeiner et al. (2000), supported by the evidence of the symbiosis between certain Bifidobacterium and lactobacilli strains (Driessen and Deboer 1989; Molly et al. 1996). Consistent with these findings, our study indicates IMO’s in vitro symbiotic effect with lactobacilli in honeybees of A. cerana. Further research is needed to confirm the symbiotic impact of IMO using honeybees.

Conclusion

In the current study, in vitro effect of prebiotics alone and combined with Lactobacillus on the microbial populations in vitro fermentation of A. cerana gut microbiota. IMO was the most favorable prebiotic to increase Bifidobacterium and LAB growth and microbial metabolic activity. Furthermore, IMO in combination with L. helveticus KM7 or L. reuteri LP4 led to a tremendous increase in Bifidobacterium and LAB and a more significant decrease in Enterococcus, fungi, and pH compared to IMO alone. These results highlight the potential of IMO as the prebiotic and symbiotic with lactobacilli for honeybee production. However, in vitro study cannot provide all the information needed to understand the effect of IMO and its mechanism fully, and further research supported by in vivo studies is warranted before ascribing prebiotic and synbiotic properties to IMO in the honey bees.

eISSN:: 2544-4646
Sprache:: Englisch

Zeitrahmen der Veröffentlichung:: 4 Hefte pro Jahr
Fachgebiete der Zeitschrift:: Biologie, Mikrobiologie und Virologie

Zeitschrift RSS Feed

In vitro Effects of Prebiotics and Synbiotics on Apis cerana Gut Microbiota

Article Category: original-paper

Online veröffentlicht: 20. Dez. 2021

Seitenbereich: 511 - 520

Eingereicht: 06. Okt. 2021

Akzeptiert: 27. Nov. 2021

DOI: https://doi.org/10.33073/pjm-2021-049

Schlüsselwörter
isomalto-oligosaccharides, lactic acid bacteria, metabolic activity

© 2021 Mingkui Lv et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1.

Fig. 2.

Fig. 3.